Dec 19, 2025 07:50AM
Nov 4, 2025 07:30AM
Aug 7, 2025 04:05PM
Jul 29, 2025 07:30AM
Jun 5, 2025 04:30PM
Jun 4, 2025 05:56AM
Jun 3, 2025 10:15PM Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
Jun 3, 2025 06:26AM
Jun 2, 2025 04:01PM
Jun 2, 2025 04:01PM
May 20, 2025 08:03AM
Apr 23, 2025 10:04AM
Mar 19, 2025 07:13AM
Mar 10, 2025 07:46AM Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
Feb 20, 2025 09:30AM
Dec 16, 2024 07:37AM
Dec 16, 2024 07:36AM
Nov 6, 2024 04:05PM
Oct 15, 2024 07:30AM
Aug 8, 2024 04:05PM
Jul 2, 2024 07:30AM Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events
Nov 9, 2023 04:05PM
Aug 10, 2023 04:05PM
Aug 1, 2023 07:30AM
Nov 10, 2022 04:05PM
Nov 8, 2022 07:30AM
Sep 23, 2022 05:52AM
Sep 22, 2022 11:26PM Trevi Therapeutics Announces Pricing of $[50 Million] Public Offering
Sep 22, 2022 04:01PM
Sep 22, 2022 04:01PM
Aug 11, 2022 04:05PM
Apr 7, 2022 08:06AM
Apr 7, 2022 08:00AM
Nov 10, 2021 04:05PM
Nov 9, 2021 07:30AM Trevi Therapeutics to Present at Stifel 2021 Virtual Healthcare Conference
Sep 30, 2021 06:57PM
Nov 10, 2020 07:30AM
Nov 10, 2020 07:30AM
Jul 13, 2020 11:42AM
Nov 13, 2019 05:01PM
Nov 13, 2019 05:01PM
Jun 3, 2019 07:16AM Stifel Starts Trevi Therapeutics (TRVI) at Buy
May 7, 2019 01:29PM
May 7, 2019 01:22PM
May 7, 2019 12:57PM

41,487 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All